Leisure Acquisition Corp. (“Leisure”) (NASDAQ: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, announced Monday that it has entered into a definitive agreement to acquire Ensysce Biosciences, Inc. (together with its affiliated entities, “Ensysce” or the “Company”). Ensysce is a clinical-stage drug company that is developing an innovative new class of powerful, tamper-proof prescription medicines that seek to prevent both drug abuse and drug overdoses.
Read the full article: Leisure Acquisition Corp. Enters into Merger Agreement for Business Combination with Ensysce Biosciences, Inc. //
Source: https://www.prnewswire.com/news-releases/leisure-acquisition-corp-enters-into-merger-agreement-for-business-combination-with-ensysce-biosciences-inc-301218847.html